Control of Th2-mediated inflammation by regulatory T cells

K. Venuprasad Poojary, Yi Chi M. Kong, Michael A. Farrar

Research output: Contribution to journalReview article

42 Citations (Scopus)

Abstract

Allergic diseases and asthma are caused by dysregulated Th2-type immune responses, which drive disease development in susceptible individuals. Immune tolerance to allergens prevents inflammatory symptoms in the respiratory mucosa and provides protection against inflammation in the airways. Increasing evidence indicates that Foxp3+ regulatory T cells (Tregs) play a critical role in immune tolerance and control Th2-biased responses. Tregs develop in the thymus from CD4 + T cells (natural Tregs) and also in the periphery by the conversion of naïve CD4 + T cells (induced Tregs). Increased susceptibility to allergy and airway inflammation is hypothesized to result from impaired development and function of Tregs. Thus, strategies to induce allergen-specific Tregs hold great promise for treatment and prevention of asthma.

Original languageEnglish (US)
Pages (from-to)525-531
Number of pages7
JournalAmerican Journal of Pathology
Volume177
Issue number2
DOIs
StatePublished - Aug 2010
Externally publishedYes

Fingerprint

Immune Tolerance
Regulatory T-Lymphocytes
Allergens
Asthma
Inflammation
T-Lymphocytes
Respiratory Mucosa
Thymus Gland
Hypersensitivity
Therapeutics

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Control of Th2-mediated inflammation by regulatory T cells. / Poojary, K. Venuprasad; Kong, Yi Chi M.; Farrar, Michael A.

In: American Journal of Pathology, Vol. 177, No. 2, 08.2010, p. 525-531.

Research output: Contribution to journalReview article

Poojary, K. Venuprasad ; Kong, Yi Chi M. ; Farrar, Michael A. / Control of Th2-mediated inflammation by regulatory T cells. In: American Journal of Pathology. 2010 ; Vol. 177, No. 2. pp. 525-531.
@article{0949f75b5c7f46289ca78ca38936e071,
title = "Control of Th2-mediated inflammation by regulatory T cells",
abstract = "Allergic diseases and asthma are caused by dysregulated Th2-type immune responses, which drive disease development in susceptible individuals. Immune tolerance to allergens prevents inflammatory symptoms in the respiratory mucosa and provides protection against inflammation in the airways. Increasing evidence indicates that Foxp3+ regulatory T cells (Tregs) play a critical role in immune tolerance and control Th2-biased responses. Tregs develop in the thymus from CD4 + T cells (natural Tregs) and also in the periphery by the conversion of na{\"i}ve CD4 + T cells (induced Tregs). Increased susceptibility to allergy and airway inflammation is hypothesized to result from impaired development and function of Tregs. Thus, strategies to induce allergen-specific Tregs hold great promise for treatment and prevention of asthma.",
author = "Poojary, {K. Venuprasad} and Kong, {Yi Chi M.} and Farrar, {Michael A.}",
year = "2010",
month = "8",
doi = "10.2353/ajpath.2010.090936",
language = "English (US)",
volume = "177",
pages = "525--531",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Control of Th2-mediated inflammation by regulatory T cells

AU - Poojary, K. Venuprasad

AU - Kong, Yi Chi M.

AU - Farrar, Michael A.

PY - 2010/8

Y1 - 2010/8

N2 - Allergic diseases and asthma are caused by dysregulated Th2-type immune responses, which drive disease development in susceptible individuals. Immune tolerance to allergens prevents inflammatory symptoms in the respiratory mucosa and provides protection against inflammation in the airways. Increasing evidence indicates that Foxp3+ regulatory T cells (Tregs) play a critical role in immune tolerance and control Th2-biased responses. Tregs develop in the thymus from CD4 + T cells (natural Tregs) and also in the periphery by the conversion of naïve CD4 + T cells (induced Tregs). Increased susceptibility to allergy and airway inflammation is hypothesized to result from impaired development and function of Tregs. Thus, strategies to induce allergen-specific Tregs hold great promise for treatment and prevention of asthma.

AB - Allergic diseases and asthma are caused by dysregulated Th2-type immune responses, which drive disease development in susceptible individuals. Immune tolerance to allergens prevents inflammatory symptoms in the respiratory mucosa and provides protection against inflammation in the airways. Increasing evidence indicates that Foxp3+ regulatory T cells (Tregs) play a critical role in immune tolerance and control Th2-biased responses. Tregs develop in the thymus from CD4 + T cells (natural Tregs) and also in the periphery by the conversion of naïve CD4 + T cells (induced Tregs). Increased susceptibility to allergy and airway inflammation is hypothesized to result from impaired development and function of Tregs. Thus, strategies to induce allergen-specific Tregs hold great promise for treatment and prevention of asthma.

UR - http://www.scopus.com/inward/record.url?scp=77957273661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957273661&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2010.090936

DO - 10.2353/ajpath.2010.090936

M3 - Review article

C2 - 20566752

AN - SCOPUS:77957273661

VL - 177

SP - 525

EP - 531

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 2

ER -